Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
NCT07045142Phase 3Recruiting
- Sponsor
- Central South University
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in glucose metabolism disorder, sponsored by Central South University. Started Jul 2025; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
glucose metabolism disorder
Beyond the preview
Go deeper on NCT07045142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045142.